• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Peter Berger, MD, Discusses the Challenges of Treating Acute Coronary Syndrome

Article

Peter Berger, MD, Chairman of Cardiology and Co-Director of the Geisinger Heart & Vascular Institute, Director, Cardiovascular Center for Clinical Research at Geisinger Clinic, thinks the biggest challenges that physicians face when treating patients with acute coronary syndrome is individualizing treatment for patients.

Peter Berger, MD, Chairman of Cardiology and Co-Director of the Geisinger Heart & Vascular Institute, Director, Cardiovascular Center for Clinical Research at Geisinger Clinic, thinks the biggest challenges that physicians face when treating patients with acute coronary syndrome is individualizing treatment for patients.

There are several anti-platelet agents with different strengths and weaknesses. It is important to figure out who should receive or avoid the most potent agents. Dr Berger says another very important thing physicians are struggling with is whether to use platelet reactivity data, or genetic information in determining what strength agent they need.

This video was taken at the American College of Cardiology's 62nd Annual Scientific Session & Expo in San Francisco, CA, on March 10, 2013.

Related Videos
Screenshot of Susan Wescott, RPh, MBA
Screenshot of an interview with Adam Colborn, JD
Screenshot of an interview with James Chambers, PhD
Screenshot of an interview with Megan Ehret, PharmD
Interview screenshot with Megan Ehret, PharmD
Screenshot of an interview with Susan Wescott, RPh, MBA
Screenshot of an interview with Nadine Barrett, PhD
Female doctor in coat with stethoscope on blue background - Pixel-Shot - stock.adobe.com
Anna-Maria Hoffmann-Vold, MD, PhD, a senior consultant and leader of inflammatory and fibrotic research area at Oslo University Hospital
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.